Association of ambulatory arterial stiffness index with sEPCR in newly diagnosed hypertensive patients

Renal Failure
Hakki YilmazAli Akcay

Abstract

Increased arterial stiffness is strongly associated with cardiovascular diseases, while thrombotic events are more common than hemorrhagic events in hypertensive patients. Markers of a hypercoagulable state may also predict future cardiovascular events in hypertensive patients. Here, we speculated that increased arterial stiffness might lead to the development of a hypercoagulable state that can play a role in the thrombotic complications of hypertension. Soluble endothelial protein C receptor (sEPCR) is one such marker of hypercoagulation. The ambulatory arterial stiffness index (AASI) could be accepted as a non-invasive measure of arterial stiffness. The aim of this study was to investigate association of AASI with levels of sEPCR in newly diagnosed hypertensive patients. The study included 263 newly diagnosed essential hypertensive patients and 55 healthy normotensive controls. All subjects underwent 24 h ambulatory blood pressure monitoring (ABPM); the AASI was derived from ABPM tracings. Plasma sEPCR was measured by ELISA. Hypertensive patients (n = 263) had higher AASI, C-reactive protein (CRP) and sEPCR versus the normotensive healthy group (n = 55). Univariate analysis showed that AASI was positively associated with age...Continue Reading

References

May 8, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·G Y H LipD G Beevers
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jun 5, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Marlies Van de WouwerEdward M Conway
Aug 12, 2004·Journal of Thrombosis and Haemostasis : JTH·S Uitte de WilligeR M Bertina
Nov 5, 2004·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Azra Mahmud, John Feely
May 26, 2005·Current Hypertension Reports·George I Varughese, Gregory Y H Lip
Mar 15, 2006·Blood Pressure Monitoring·Eamon DolanAlice Stanton
Aug 5, 2006·Current Opinion in Hematology·Charles T Esmon
Oct 21, 2006·Journal of Hypertension·Tine W HansenJørgen Jeppesen
May 11, 2007·Expert Review of Cardiovascular Therapy·Puneet Kakar, Gregory Y H Lip
Jun 22, 2007·Clinical and Experimental Pharmacology & Physiology·Sophia Zoungas, Roland P Asmar
Jan 15, 2008·Journal of Hypertension·Giuseppe Schillaci, Gianfranco Parati
May 30, 2008·Journal of Human Hypertension·I Z Ben-DovM Bursztyn
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Feb 5, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Veronique RegnaultPatrick Lacolley
Jan 14, 2012·Journal of Hypertension·Jan G KipsPatrick Segers
Jan 28, 2012·Stroke; a Journal of Cerebral Circulation·Konstantinos AznaouridisChristodoulos Stefanadis
Mar 27, 2012·Journal of Cardiovascular Translational Research·Julio A Chirinos
May 29, 2012·Atherosclerosis·Anastasios KolliasEoin O'Brien
Jul 17, 2012·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·C CatenaF Fallo
Oct 2, 2012·Scandinavian Journal of Clinical and Laboratory Investigation·Jedrzej WykretowiczAndrzej Wykretowicz
May 17, 2014·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Carol KotliarFelipe Inserra

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.